| |
|
|
|
|
|
|
|||
|
Prepublished online as a Blood First Edition Paper on February 27, 2003; DOI 10.1182/blood-2002-05-1504.
Blood, 15 June 2003, Vol. 101, No. 12, pp. 4870-4877
Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
R. F. Kalejta Tegument Proteins of Human Cytomegalovirus Microbiol. Mol. Biol. Rev., June 1, 2008; 72(2): 249 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rodriguez, L. Zoecklein, J. G. Kerkvliet, K. D. Pavelko, L. Papke, C. L. Howe, L. R. Pease, and C. David Human HLA-DR Transgenes Protect Mice from Fatal Virus-Induced Encephalomyelitis and Chronic Demyelination J. Virol., April 1, 2008; 82(7): 3369 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation J. Virol., May 1, 2007; 81(9): 4389 - 4396. [Full Text] [PDF] |
||||
![]() |
A. W. Lee, L. Hertel, R. K. Louie, T. Burster, V. Lacaille, A. Pashine, D. A. Abate, E. S. Mocarski, and E. D. Mellins Human Cytomegalovirus Alters Localization of MHC Class II and Dendrite Morphology in Mature Langerhans Cells J. Immunol., September 15, 2006; 177(6): 3960 - 3971. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Odeberg, N. Wolmer, S. Falci, M. Westgren, A. Seiger, and C. Soderberg-Naucler Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol., September 1, 2006; 80(18): 8929 - 8939. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sinzger, K. Eberhardt, Y. Cavignac, C. Weinstock, T. Kessler, G. Jahn, and J.-L. Davignon Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules J. Gen. Virol., July 1, 2006; 87(7): 1853 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Trgovcich, C. Cebulla, P. Zimmerman, and D. D. Sedmak Human Cytomegalovirus Protein pp71 Disrupts Major Histocompatibility Complex Class I Cell Surface Expression J. Virol., January 15, 2006; 80(2): 951 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Ressing, D. van Leeuwen, F. A. W. Verreck, S. Keating, R. Gomez, K. L. M. C. Franken, T. H. M. Ottenhoff, M. Spriggs, T. N. Schumacher, L. M. Hutt-Fletcher, et al. Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion J. Virol., January 15, 2005; 79(2): 841 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Abate, S. Watanabe, and E. S. Mocarski Major Human Cytomegalovirus Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation in the Interferon Response J. Virol., October 15, 2004; 78(20): 10995 - 11006. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Jones and S.-W. Lee An Acidic Cluster of Human Cytomegalovirus UL99 Tegument Protein Is Required for Trafficking and Function J. Virol., February 1, 2004; 78(3): 1488 - 1502. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||